Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cephalosporins.

M G Martens1

  • 1Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas.

Obstetrics and Gynecology Clinics of North America
|June 1, 1989
PubMed
Summary
This summary is machine-generated.

Cephalosporins are effective for obstetric and gynecologic infections, offering broader spectra and improved pharmacokinetics. Careful monitoring minimizes risks like superinfection and resistance, ensuring patient safety and therapeutic success.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Roundtable discussion of antibiotic therapy in surgical infections.

Surgical infections·2003
Same author

Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue.

Gynecologic oncology·2000
Same author

Experimental gestational pyelonephritis induces preterm births and low birth weights in C3H/HeJ mice.

Infection and immunity·1999
Same author

Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis.

Sexually transmitted diseases·1999
Same author

Penetration of trovafloxacin into gynecologic tissues.

American journal of surgery·1999
Same author

Treatment of acute gynecologic infections with trovafloxacin. Trovafloxacin Surgical Group.

American journal of surgery·1999
Same journal

Bridging Science and Practice in Gender-Affirming Care: A Compendium for Gynecologists.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evidence, Clinical Expertise, and Research Gaps in Gender-Affirming Care.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evaluation and Management of the Pediatric Gender-Diverse Patient.

Obstetrics and gynecology clinics of North America·2026
Same journal

Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.

Obstetrics and gynecology clinics of North America·2026
Same journal

Updates on Breast Cancer Screening and Special Considerations for Transgender Men and Women.

Obstetrics and gynecology clinics of North America·2026
Same journal

Contraceptive Needs of the Transmasculine Patient.

Obstetrics and gynecology clinics of North America·2026
See all related articles

Area of Science:

  • Obstetrics and Gynecology
  • Infectious Diseases
  • Pharmacology

Background:

  • Cephalosporins are widely used for obstetric and gynecologic infections.
  • Their broad spectra and improved pharmacokinetics offer advantages over traditional treatments.

Purpose of the Study:

  • To review the efficacy and safety of cephalosporins in obstetric and gynecologic care.
  • To highlight the benefits and potential risks associated with cephalosporin use.

Main Methods:

  • Literature review of cephalosporin applications in obstetrics and gynecology.
  • Analysis of pharmacokinetic properties and antimicrobial spectra.
  • Evaluation of adverse effects and resistance patterns.

Main Results:

Related Experiment Videos

  • Cephalosporins demonstrate broad-spectrum activity, enabling single-agent therapy.
  • Improved pharmacokinetics allow for reduced dosing frequency.
  • Substitution for aminoglycosides reduces potential renal and otic toxicity.

Conclusions:

  • Cephalosporins offer significant benefits in managing obstetric and gynecologic infections.
  • Potential adverse effects like superinfection and resistance are infrequent and manageable.
  • Increased knowledge of cephalosporin properties enhances patient outcomes, safety, and cost-effectiveness.